Effects of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate on liver proteoglycan synthesis.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002809:Chondroitin Sulfates / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology*; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D006497:Heparan Sulfate / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D011509:Proteoglycans / Q000096:biosynthesis*; D051381:Rats; D011919:Rats, Inbred Strains
D003994:Bucladesine; D002809:Chondroitin Sulfates; D000242:Cyclic AMP; D006152:Cyclic GMP; D003995:Dibutyryl Cyclic GMP; D006497:Heparan Sulfate; D011509:Proteoglycans